Nicholas G. Davies - Concepedia

Author

Nicholas G. Davies

London School of Hygiene & Tropical Medicine

Also Known As

Akira Endo, Alicia Rosello, Brian MacKenna, Cariad Evans, Christopher I Jarvis, Davies, Davies, Nicholas, Davies, Nicholas G, Davies, Nicholas G., Emily S. Nightingale

Publications

13.5K

Citations

H-Index

Concepts

All Affiliations

London School of Hygiene & Tropical Medicine Public Health England Granta Design (United Kingdom)Ministry of National Health Services Regulation and Coordination Stellenbosch University

About

Nicholas G. Davies is an author at London School of Hygiene & Tropical Medicine specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.6K
2	Public Health	3	3	3.7K
3	Natural Sciences	2	2	55
4	Engineering	1	1	10
5	Biomolecular Engineering	1	1	10

Nicholas G. Davies

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Early dynamics of transmission and control of COVID-19: a mathematical modelling study Adam J. Kucharski, Timothy Russell, Charlie Diamond, The Lancet Infectious Diseases	2020	2.6K
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study Kiesha Prem, Yang Liu, Timothy Russell, The Lancet Public Health Infectious Disease ModellingCovid-19 PandemicEpidemiological DynamicSocial MixingModelling Study	2020	2.3K
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study Andrew Clark, Mark Jit, Charlotte Warren‐Gash, The Lancet Global Health Infectious Disease EpidemiologyEpidemiological TrendGlobal HealthGlobal Health CrisisEpidemiological Dynamic	2020	1.2K
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study Nicholas G. Davies, Adam J. Kucharski, Rosalind M. Eggo, The Lancet Public Health	2020	963
4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer Paul A. Brough, Wynne Aherne, Xavier Barril, Journal of Medicinal Chemistry	2007	442
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection Kaja Abbas, Simon R. Procter, Kevin van Zandvoort, The Lancet Global Health	2020	369
Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era Kiesha Prem, Kevin van Zandvoort, Petra Klepac, PLoS Computational Biology	2021	251
The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China Kiesha Prem, Yang Liu, Timothy Russell, Epidemiological DynamicSocial MixingCovid-19 EpidemiologySocial Determinants Of HealthCovid-19	2020	241
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation Frank Sandmann, Nicholas G. Davies, Anna Vassall, The Lancet Infectious Diseases	2021	190
Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-<i>d</i>]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone Paul A. Brough, Xavier Barril, Jenifer Borgognoni, Journal of Medicinal Chemistry	2009	173

Page 1